Uncategorized

Is breast cancer care across Europe good enough?

Obtaining the right mix of patients from different ethnic, racial and demographic backgrounds requires a strategic approach leveraging community-based resources and patient-friendly technologies

PharmaTimes’ Editor John Pinching talks to AstraZeneca’s inspiring diversity and inclusion leader for Europe and Canada, Anna-Lena Engwall

England’s prescribing trends provide a host of intriguing insights

Digging deep into the maelstrom of intellectual property in pharma

Data quality governance – dispelling five common myths

How can we use precision medicine to improve heart failure care?

We must look after an entire nation’s health – regardless of wealth

Pharmacy’s central role in women’s health – including the menopause – must reflect a more modern, tailored approach

As the NHS remains in intensive care, its long-term future is shrouded in doubt

Realigning R&D to reduce inequities in health and drive local prosperity

Customer-centric pharma is a challenging road, but it’s worth it

Why we must protect and accelerate the innovation that creates life-saving treatments

Intelligent resourcing – what it means and why it’s important for companies

Navigating the complexity of regulatory classification in bioprinting